ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 272 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,666,417 | +233.0% | 65,607 | +431.7% | 0.00% | +100.0% |
Q4 2022 | $500,429 | +21.2% | 12,338 | -1.3% | 0.00% | 0.0% |
Q3 2022 | $413,000 | -6.1% | 12,498 | +30.7% | 0.00% | – |
Q1 2022 | $440,000 | -75.5% | 9,561 | -66.7% | 0.00% | -100.0% |
Q3 2021 | $1,795,000 | -22.1% | 28,754 | -17.3% | 0.00% | -33.3% |
Q1 2021 | $2,305,000 | +19.3% | 34,758 | +38.0% | 0.00% | 0.0% |
Q4 2020 | $1,932,000 | -33.9% | 25,182 | -62.9% | 0.00% | -40.0% |
Q3 2020 | $2,923,000 | -12.0% | 67,874 | -11.8% | 0.01% | -16.7% |
Q2 2020 | $3,323,000 | +31.6% | 76,933 | -12.3% | 0.01% | 0.0% |
Q1 2020 | $2,525,000 | -80.3% | 87,766 | -56.6% | 0.01% | -72.7% |
Q4 2019 | $12,841,000 | +221.8% | 202,442 | +43.0% | 0.02% | +175.0% |
Q3 2019 | $3,990,000 | -13.2% | 141,586 | -18.4% | 0.01% | -11.1% |
Q2 2019 | $4,595,000 | +741.6% | 173,413 | +482.3% | 0.01% | +800.0% |
Q1 2019 | $546,000 | -75.4% | 29,781 | -83.3% | 0.00% | -80.0% |
Q4 2018 | $2,220,000 | – | 178,720 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |